Interferon-? Mediates Lung Damage through the Hyper-Activation of CCR2+ Inflammatory Monocytes during Influenza Virus Infection

Text Registration

Interferon-? Mediates Lung Damage through the Hyper-Activation of CCR2+ Inflammatory Monocytes during Influenza Virus Infection

Status

Published

on 1 Oct 2020

Year of Creation

2020

Mitchell Anthony Klomp

Registration Number

TX0008918871

on 1 Oct 2020

The U.S. Copyright record (Registration Number: TX0008918871) dated 1 Oct 2020, pertains to an electronic file (eService) titled "Interferon-? Mediates Lung Damage through the Hyper-Activation of CCR2+ Inflammatory Monocytes during Influenza Virus Infection" created in 2020. The copyright holder is Mitchell Anthony Klomp, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Mitchell Anthony Klomp.

Mitchell Anthony Klomp

Application Details

Registration Number

TX0008918871

Registration Date

10/1/2020

Year of Creation

2020

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Mitchell Anthony Klomp

Notes

Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Interferon-? Mediates Lung Damage through the Hyper-Activation of CCR2+ Inflammatory Monocytes during Influenza Virus Infection

Author Statement: Mitchell Anthony Klomp Citizenship: not known Authorship: text

Notes

Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Interferon-? Mediates Lung Damage through the Hyper-Activation of CCR2+ Inflammatory Monocytes during Influenza Virus Infection

Author Statement: Mitchell Anthony Klomp Citizenship: not known Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.